Glycogen storage diseases, Rev. Endocr. Metab. Disord, vol.4, pp.95-102, 2003. ,
Animal models of glycogen storage disorders, Prog. Mol. Biol. Transl. Sci, vol.100, pp.369-388, 2011. ,
Regulation of glucose metabolism from a liver-centric perspective, Exp. Mol. Med, vol.48, p.218, 2016. ,
Glycogen metabolism in humans, BBA Clin, vol.5, pp.85-100, 2016. ,
Mutations in the glucose-6-phosphatasealpha (G6PC) gene that cause type Ia glycogen storage disease, Hum. Mutat, vol.29, pp.921-930, 2008. ,
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex, Curr. Mol. Med, vol.2, pp.121-143, 2002. ,
Historical highlights and unsolved problems in glycogen storage disease type 1, Eur. J. Pediatr, vol.161, issue.1, pp.2-9, 2002. ,
Glycogen storage diseases: new perspectives, World J. Gastroenterol, vol.13, pp.2541-2553, 2007. ,
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics, American College of Medical Genetics and Genomics, vol.16, p.1, 2014. ,
Gut-brain glucose signaling in energy homeostasis, Cell Metab, vol.25, pp.1231-1242, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02339600
Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon, Diabetes, vol.60, pp.3121-3131, 2011. ,
, , 2012.
, Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism, J. Clin. Lipidol, vol.6, pp.596-600
Mechanisms by which metabolic reprogramming in GSD1 liver generates a favorable tumorigenic environment, J. Inborn Errors Metab. Screen, vol.4, p.2326409816679429, 2016. ,
Hepatocellular carcinoma in glycogen storage disease type Ia: a case series, J. Inherit. Metab. Dis, vol.28, pp.153-162, 2005. ,
Natural history of hepatocellular adenoma formation in glycogen storage disease type I, J. Pediatr, vol.159, pp.442-446, 2011. ,
Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: a case report, Mol. Clin. Oncol, vol.5, pp.599-603, 2016. ,
An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia, J. Hepatol, vol.53, pp.213-217, 2010. ,
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I, J. Hepatol, vol.58, pp.350-357, 2013. ,
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome, J. Inherit. Metab. Dis, vol.39, pp.697-704, 2016. ,
Glycogen storage disease type III diagnosis and management guidelines, Genet. Med, vol.12, pp.446-463, 2010. ,
Molecular characterization of glycogen storage disease type III, Curr. Mol. Med, vol.2, pp.167-175, 2002. ,
Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control, J. Inherit. Metab. Dis, vol.31, pp.729-732, 2008. ,
Mouse model of glycogen storage disease type III, Mol. Genet. Metab, vol.111, pp.467-476, 2014. ,
Glycogen storage disease type III: a novel Agl knockout mouse model, Biochim. Biophys. Acta, vol.1842, pp.2318-2328, 2014. ,
Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma, The Liver Transplant Group, vol.25, pp.537-540, 1997. ,
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease, J. Clin. Gastroenterol, vol.31, pp.80-82, 2000. ,
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?, J. Hepatol, vol.46, pp.492-498, 2007. ,
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J. Hepatol, vol.54, pp.529-537, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00575314
Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations, J. Pediatr, vol.140, pp.781-783, 2002. ,
Mutational analysis of the GYS2 gene in patients diagnosed with ketotic hypoglycaemia, J. Pediatr. Endocrinol. Metab, vol.25, pp.963-967, 2012. ,
The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency, J. Pediatr. Endocrinol. Metab, vol.30, pp.459-462, 2017. ,
Emerging therapies for glycogen storage disease type I, Trends Endocrinol. Metab, vol.20, pp.252-258, 2009. ,
Investigation and management of the hepatic glycogen storage diseases, Transl. Pediatr, vol.4, pp.240-248, 2015. ,
Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet, Pediatr. Res, vol.70, pp.638-641, 2011. ,
Correction of glycogen storage disease type III with rapamycin in a canine model, J. Mol. Med. (Berl.), vol.92, pp.641-650, 2014. ,
Glycogen storage disease type VI, 2009. ,
natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada, The www.moleculartherapy.org Molecular Therapy, vol.26, pp.171-176, 2014. ,
Cardiac pathology in glycogen storage disease type III, JIMD Rep, vol.6, pp.65-72, 2012. ,
Skeletal and cardiac muscle involvement in children with glycogen storage disease type III, Eur. J. Pediatr, vol.174, pp.1545-1548, 2015. ,
Silencing myostatin using cholesterolconjugated siRNAs induces muscle growth, Mol. Ther. Nucleic Acids, vol.5, p.342, 2016. ,
Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment, Pediatr. Nephrol, vol.5, pp.71-76, 1991. ,
Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide, J. Biol. Chem, vol.279, pp.48434-48442, 2004. ,